Alibaba Completes HK$80B Share Placement: Major Dilution to Fund AI/Cloud

What happened

Alibaba Group announced the completion of an HK$80 billion placement of 710 million newly issued ordinary shares at HK$112.70 per share, representing roughly a 30% increase in share count and raising about US$10.3 billion. The company stated the proceeds are intended for general corporate purposes, but given its recent aggressive AI and cloud infrastructure investment, the funds are likely earmarked to support the US$53 billion AI buildout and shore up liquidity after FY2026 free cash flow turned negative. This placement follows a period of heavy capital expenditure that pushed Alibaba's FY2026 free cash flow to negative RMB46.6 billion and reduced its cash and liquid investments from RMB597.1 billion to RMB520.8 billion year over year. While the equity raise alleviates near-term balance sheet pressure and may fund high-return AI capacity, it introduces significant per-share dilution that lowers the value of existing shareholders' stakes unless the new capital generates returns above the cost of equity. The placement price appears roughly in line with market levels at the time, but the sheer size of the offering suggests management is prioritizing scale and speed over preserving per-share economics, a decision investors must weigh against execution risks and geopolitical headwinds.

Implication

Investors should treat this equity raise as a red flag that internal cash generation is insufficient to fund Alibaba's AI ambitions, forcing external funding at a time of heavy capex and negative free cash flow. The immediate effect is a roughly 30% increase in share count, which mechanically lowers earnings per share and the intrinsic value per share across all scenario probabilities from the prior report. The success of this capital raise hinges entirely on whether the new funds accelerate cloud monetization and return Alibaba to positive free cash flow within 12-24 months. Until then, the dilution and the uncertain payoff from AI spending keep the stock in a 'show me' phase, and the prior WAIT rating remains appropriate with a lower per-share valuation anchor. The attractive entry level likely needs to be adjusted downward to account for the increased share supply, and investors should monitor whether management slows buybacks or continues to dilute instead of funding growth organically.

Thesis delta

The prior thesis viewed Alibaba as a wait-and-see story with balanced risk-reward at $96.1. This placement shifts the balance modestly negative because it adds substantial dilution and indicates that management is willing to tap equity markets rather than rely on internal cash flow to fund the AI transition. While the capital may strengthen the balance sheet and accelerate AI capacity, it reduces per-share value and raises the bar for what the new expenditures must achieve to justify the existing share price.